[Other] Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors.

rahta1973 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-14 14:33
Reward20points

journalㄩJournal of Clinical Oncology

AuthorsㄩJennifer Rachel Eads; Smitha S. Krishnamurthi; Joel N. Saltzman; David Lawrence Bajor; Shaveta Vinayak; Jill Barnholtz-Sloan; Neal J. Meropol; Sanford D. Markowitz; Zhenghe Wang

Published dateㄩ2018-5-20

DOIㄩ10.1200/jco.2018.36.15_suppl.2562

PDF linkㄩhttp://ascopubs.org/doi/pdfdirec ... 18.36.15_suppl.2562

Article linkㄩhttps://doi.org/10.1200/jco.2018.36.15_suppl.2562

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    50


Daily Top Contributors

Return to the list